Digestive and Liver Disease
Volume 41, Issue 8 , Pages 541-550, August 2009

Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver

  • L. Elli

      Affiliations

    • Center for Prevention and Diagnosis of Celiac Disease, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, via F. Sforza, Milan, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +30 02 55033384; fax: +30 02 50320403.
  • ,
  • C.M. Bergamini

      Affiliations

    • Department of Biochemistry, University of Ferrara, Via Luigi Borsari, Ferrara, Italy
  • ,
  • M.T. Bardella

      Affiliations

    • Center for Prevention and Diagnosis of Celiac Disease, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, via F. Sforza, Milan, Italy
    • Department of Medical Sciences, University of Milan, via F. Sforza, Milan, Italy
  • ,
  • D. Schuppan

      Affiliations

    • Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Ave, MA Boston, USA

Received 28 August 2008; accepted 2 December 2008. published online 05 February 2009.

Abstract 

Transglutaminases are a family of eight currently known calcium-dependent enzymes that catalyze the cross-linking or deamidation of proteins. They are involved in important biological processes such as wound healing, tissue repair, fibrogenesis, apoptosis, inflammation and cell-cycle control. Therefore, they play important roles in the pathomechanisms of autoimmune, inflammatory and degenerative diseases, many of which affect the gastrointestinal system.

Transglutaminase 2 is prominent, since it is central to the pathogenesis of celiac disease, and modulates inflammation and fibrosis in inflammatory bowel and chronic liver diseases.

This review highlights our present understanding of transglutaminase function in gastrointestinal and liver diseases and therapeutic strategies that target transglutaminase activities.

Keywords: Celiac disease, Collagen, Crohn's disease, Extracellular matrix, Gliadin, Inflammatory bowel disease, NFkB, Ulcerative colitis

 

PII: S1590-8658(08)00860-8

doi:10.1016/j.dld.2008.12.095

Digestive and Liver Disease
Volume 41, Issue 8 , Pages 541-550, August 2009